Clinical Trials Logo

Filter by:
NCT ID: NCT06296147 Recruiting - Prostate Cancer Clinical Trials

Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if a VR headset and/or aromatherapy can be used to reduce patient pain, anxiety, and embarrassment during a transperineal biopsy (TPBx) compared to standard of care (SOC). The primary objective is to evaluate differences in self-reported pain, fear, or embarrassment during and after the procedure between the VR Group, Aromatherapy Group, VR+Aromatherapy Group, and the Control group.

NCT ID: NCT06295965 Recruiting - Clinical trials for Recurrent Ovarian Carcinoma

Clonal Hematopoiesis in Ovarian Cancer Survivors and Risk of Secondary Blood Cancers

Start date: January 2, 2024
Phase:
Study type: Observational

This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancers. Researchers want to identify risk factors for developing these blood cancers as well as if there is/are a genetic/environmental component(s) to developing blood cancer.

NCT ID: NCT06295952 Recruiting - Clinical trials for Prolactin-Producing Pituitary Tumor

A Study of Pasireotide in People With Prolactinoma

Start date: February 27, 2024
Phase: Phase 2
Study type: Interventional

The researchers are doing this study to find out whether pasireotide is an effective treatment for people with prolactinoma who cannot receive dopamine agonist therapy. Another purpose of this study is to find out whether pasireotide is a safe treatment for people with prolactinoma.

NCT ID: NCT06295770 Recruiting - Clinical trials for Fibrillary Glomerulonephritis

Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

Start date: June 24, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this research is to learn if Obinutuzumab is effective and safe in treating patients with fibrillary glomerulonephritis (FGN).

NCT ID: NCT06295744 Recruiting - Clinical trials for Early-stage Breast Cancer

Outcomes and Cosmesis With Whole Breast Irradiation and Boost

Start date: April 17, 2024
Phase: N/A
Study type: Interventional

This study is being done to evaluate cosmetic, patient-reported outcome measures (PROMs), and toxicities for women undergoing ultra-short whole breast irradiation (WBI) therapy with simultaneous integrated boost (SIB). 50 participants will be on study for up to 60 months.

NCT ID: NCT06295731 Recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma (HNSCC)

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Start date: May 14, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

This seamless phase 2/3 randomized controlled study will evaluate the efficacy and safety of the hexavalent OX40 agonist antibody INBRX-106 combined with the anti-PD-1 antibody pembrolizumab versus pembrolizumab (+ placebo in phase 3) as first-line treatment for patients with locally advanced recurrent or metastatic head and neck squamous cell carcinoma (R/M HSNSCC) incurable by local therapies, expressing PD-L1 with a combined proportion score (CPS) ≥20.

NCT ID: NCT06295705 Recruiting - Clinical trials for Autism Spectrum Disorder

Exploring the Effectiveness of Dance as an Intervention to Promote Social-Emotional Health in Children With Autism Spectrum Disorder (ASD)

ASD
Start date: April 2, 2024
Phase: N/A
Study type: Interventional

This study will explore the effectiveness of dance as an intervention to promote social-emotional health within children with ASD.

NCT ID: NCT06295523 Recruiting - Aging Clinical Trials

Heat Waves and the Elderly With COPD

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate thermoregulatory responses in older individuals with COPD.

NCT ID: NCT06295393 Recruiting - Sepsis Clinical Trials

Renin Angiotensin Aldosterone System In Septic Kids

RISK
Start date: January 24, 2024
Phase:
Study type: Observational

Prospective observational cohort study; pediatric sepsis vs. healthy pediatric subjects and pediatric sepsis with acute kidney injury (AKI) vs without AKI. Blood samples and renal ultrasound will be collected on sequential days for septic subject and one time for the healthy patients. Enzyme-linked immunosorbent assays (ELISA) with be run on serum plasma to compare the renin-angiotensin-aldosterone system (RAAS) between groups.

NCT ID: NCT06295367 Recruiting - Clinical trials for Malignant Solid Neoplasm

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Start date: February 29, 2024
Phase: N/A
Study type: Interventional

This clinical trial evaluates the effect of Cost Communication and Financial Navigation (CostCOM) intervention on adherence to care and financial burden in cancer patients. Many cancer patients experience financial hardship due to high medical out of pocket costs (OOPC), changes in employment, income and insurance. Financial hardship can lead to a delay or a stop in cancer care, and is linked to poor quality of life. Financial navigation programs, such as CostCOM, provide financial counseling, education and connections to appropriate resources to reduce financial barriers to healthcare and minimize financial stress and burden. CostCOM may improve adherence to care and decrease financial burden in patients with cancer.